Skip to main content
. 2020 Jun 12;25:e922723-1–e922723-9. doi: 10.12659/AOT.922723

Figure 1.

Figure 1

(A) Kaplan-Meier survival curve for all patients. (B) Kaplan-Meier survival curves for patients who received hepatitis C virus (HCV) nucleic acid testing (NAT) positive organs (blue) compared to those who received organs with negative HCV NAT or unknown NAT status (red).